Replies to post #323776 on Elite Pharmaceuticals Inc (ELTP)

[virelle]

BASED SOLELY ON CURRENTLY APPROVED DRUGS, ELITE WILL BECOME CASH FLOW POSITIVE WITH TOTAL ANNUALIZED REVENUES IN EXCESS OF $20 MILLION!

and now, add this to the bottom line of products already approved:

September 2019 Approved Tylenol with codiene $45 million
November 2019 Approval Sungen#3 $94 million
December 2019 Approval Sungen#2 $1.6 Billion
Loxapine transfer approval in two months

and add also this to the previous products

Filing Sungen#4 $70 million
Filing Sungen#5 $1.5 Billion